These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 6325836)

  • 21. [Immunological study of nasopharyngeal carcinoma].
    Tachibana T
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1387-98. PubMed ID: 4327018
    [No Abstract]   [Full Text] [Related]  

  • 22. [Seroepidemiology of Epstein-Barr virus].
    Pannuti CS
    Rev Saude Publica; 1981 Feb; 15(1):93-100. PubMed ID: 6275491
    [No Abstract]   [Full Text] [Related]  

  • 23. IgA and nasopharyngeal carcinoma.
    Desgranges C; De-The G
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE; Giraudo Conesa LC; Braun M
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection.
    Lai PK; Alpers MP
    Comp Immunol Microbiol Infect Dis; 1979; 2(4):565-85. PubMed ID: 232867
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
    Nishioka K; Tachibana T; Hirayama T; De Thé G; Klein G
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1398-406. PubMed ID: 4326465
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sero-epidemiologic studies of Epstein-Barr virus in Israel].
    Oren U; Gotlieb-Stematsky T; Doley E; Modan M
    Harefuah; 1978 Mar; 94(5-6):171-2. PubMed ID: 207624
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for an oncogenic potential of the Epstein-Barr virus.
    Henle W; Henle G
    Cancer Res; 1973 Jun; 33(6):1419-23. PubMed ID: 4352376
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA; Morgan AJ
    Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
    [No Abstract]   [Full Text] [Related]  

  • 32. Epstein-Barr virus. Is it timely to discuss a vaccine?
    Biomedicine; 1978; 28(1):15-7. PubMed ID: 208671
    [No Abstract]   [Full Text] [Related]  

  • 33. Epstein-Barr virus (EBV) specific T and K cell cytotoxicity in vitro.
    Jondal M; Svedmyr E; Klein E; Klein G
    Bibl Haematol; 1975 Oct; (43):265-9. PubMed ID: 183683
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.
    Ooka T; de Turenne-Tessier M; Stolzenberg MC
    Springer Semin Immunopathol; 1991; 13(2):233-47. PubMed ID: 1664988
    [No Abstract]   [Full Text] [Related]  

  • 35. Host responses to herpesviruses - a review.
    Henle W; Henle G
    IARC Sci Publ (1971); 1975; (11 Pt 2):215-24. PubMed ID: 191365
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
    Svedmyr A; Demissie A; Klein G; Clifford P
    J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epstein-Barr virus as an etiological factor in infectious mononucleosis and other diseases].
    Kacprzak-Bergman I; Rudkowski Z
    Pediatr Pol; 1977 Nov; 52(11):1293-7. PubMed ID: 201912
    [No Abstract]   [Full Text] [Related]  

  • 38. [The diagnostic value of Epstein-Barr virus diagnosis].
    Bauer G
    Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107
    [No Abstract]   [Full Text] [Related]  

  • 39. [Burkitt's lymphoma].
    Gombos F; Serpico R; Femiano F
    Arch Stomatol (Napoli); 1984; 25(4):329-38. PubMed ID: 6100729
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunologic tests: Epstein-Barr virus].
    Mizuno F
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():300-3. PubMed ID: 16111256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.